Probable cerebral amyloid angiopathy - related inflammation in a 32-year-old woman with down syndrome

Inflammatory cerebral amyloid angiopathy (CAA-RI) is a variant of CAA, rarely seen in young individuals with Down syndrome (DS). We describe a 32-year-old female with DS who developed a systemic inflammatory state followed by acute neurological symptoms, including seizures and hemiparesis. Brain MRI disclosed asymmetric T2/FLAIR hyperintensities with leptomeningeal enhancement and focal superficial siderosis on susceptibility-weighted imaging, without microbleeds; cerebrospinal fluid showed marked inflammation. After partial improvement with corticosteroids, rituximab was started due to persistent symptoms. This case highlights CAA-RI as a cause of acute decline in DS and supports the use of rituximab in refractory cases.

Authors

Institutions

Publication Details

Journal
Neurogenetics
Published
2026-02-12
DOI
https://doi.org/10.1007/s10048-026-00883-6
Primary Topic
Intracerebral and Subarachnoid Hemorrhage Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Probable cerebral amyloid angiopathy - related inflammation in a 32-year-old woman with down syndrome

Jorge Alberto Martins Pentiado, Mateus Gustavo Favaro, Lucas Ravagnani Silva, Thales Pardini Fagundes et al.
Neurogenetics
Intracerebral and Subarachnoid Hemorrhage Research
article

Probable cerebral amyloid angiopathy - related inflammation in a 32-year-old woman with down syndrome

Jorge Alberto Martins Pentiado, Mateus Gustavo Favaro, Lucas Ravagnani Silva, Thales Pardini Fagundes, Joyce Yuri Silvestre Yamamoto, Lucas Giansante Abud, Gustavo Maximiano Alves
article en

Abstract

Inflammatory cerebral amyloid angiopathy (CAA-RI) is a variant of CAA, rarely seen in young individuals with Down syndrome (DS). We describe a 32-year-old female with DS who developed a systemic inflammatory state followed by acute neurological symptoms, including seizures and hemiparesis. Brain MRI disclosed asymmetric T2/FLAIR hyperintensities with leptomeningeal enhancement and focal superficial siderosis on susceptibility-weighted imaging, without microbleeds; cerebrospinal fluid showed marked inflammation. After partial improvement with corticosteroids, rituximab was started due to persistent symptoms. This case highlights CAA-RI as a cause of acute decline in DS and supports the use of rituximab in refractory cases.

NeurogeneticsVol. 27(1)
Universidade de São Paulo (BR), Hospital de Câncer de Barretos (BR), Clinics Hospital of Ribeirão Preto (BR)
Good health and well-being
Openalex Percentile: Top 61%
Intracerebral and Subarachnoid Hemorrhage Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.